The Drug Controller General of India (DCGI) has given conditional market approval to companies for Covishield and Covaxin. But the vaccine will not be available at the medical store. Vaccines can be purchased from hospitals and clinics only. Vaccination data has to be submitted to DCGI every six months. The data will also be updated on the Covin app.
India's drug regulator on Thursday approved the regular sale of the Covid 19 vaccines Covishield and Covaxin for use in the adult population, subject to certain conditions. Approval has been given under the New Drugs and Clinical Trials Rules, 2019. Under the conditions, firms will submit data on vaccines to be supplied for ongoing clinical trials and programmatic settings. Monitoring for any adverse event will continue after vaccination.
Mansukh Mandaviya also gave information
At the same time, Union Health Minister Dr. Mansukh Mandaviya said that the Central Drugs Standard Control Organization (CDSCO) has now upgraded the permission of Covaxin and Covishield from restricted use in emergencies to the permission of generic new drugs in the adult population with certain conditions.
was recommended on January 19
Serum Institute of India (SII) for use in an adult population subject to certain conditions after approval of Drug Controller General of India (DCGI) by Subject Expert Committee (SEC) on COVID-19 of Central Drugs Standard Control Organization (CDSCO) on 19 Jan. K Covishield and Bharat Biotech's Covaxin were recommended for approval for regular market sale.
Both companies had submitted data and information
On October 25, Prakash Kumar Singh, director of government and regulatory affairs at SII, had submitted an application to DCGI seeking permission to sell Covishield in the market regularly. Singh had recently submitted more data and documents after DCGI had sought more data and documents from the Pune-based company. He had said that such large-scale vaccination and prevention of corona infection with Covidshield is in itself proof of the safety and efficacy of the vaccine.
Meanwhile, in an application sent to DCGI, V Krishna Mohan, the whole-time director at Hyderabad-based Bharat Biotech, had submitted clinical data as well as complete details of chemistry, manufacturing, and control, seeking approval to launch Covaxin.
A five-match T20 series is being played between India and South Africa. The South African team ha
Sushant Singh Rajput had a huge fan following in Bollywood. On June 14, 2020, Sushant's body was
Ladakh, Maharashtra, and now Arunachal Pradesh. Earthquake tremors have been felt in three states
On Congress leader Rahul Gandhi calling the exit polls (Exit Polls 2024) a 'Modi Media Poll' and
IND vs SL: Rishabh Pant or Sanju Samson? Gautam faced a serious problem on his first tour.
It will be challenging for the newly appointed head coach of the Indian cricket team, Gautam Gamb
In Pakistan's Punjab Assembly, Imran's party leaders slapped the deputy speaker, pulled hair too
In the Punjab Assembly of Pakistan, on Saturday, the leaders of Imran Khan's party PTI broke the
After the Supreme Court in the US overturned its 49-year-old decision that legalized abortion, th
The interim order of the Karnataka High Court in the Karnataka Hijab case has now been challenged
Weather Update: Mercury below zero in Kashmir, Delhi colder than Mussoorie, cold wave in Rajasthan
Fog has started spreading in different states of the country amidst increasing cold. The mercury
The hearing in the Supreme Court on the ongoing political turmoil in Pakistan continues for the f
